5Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Glob- al cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
6Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012; 62(4): 220-41.
7Chen L, Zhu Z, Sun X, Dong XY, Wei J, Gu F, et al. Down- regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis. Breast Cancer Res Treat 2009; 116(3): 471-8.
8Kitamoto S, Yamada N, Yokoyama S, Houjou I, Higashi M, Yonezawa S. Promoter hypomethylation contributes to the ex- pression of MUC3A in cancer cells. Biochem Biophys Res Com- mun 2010; 397(2): 333-9.
9Perry AS, Foley R, Woodson K, Lawler M. The emerging roles of DNA methylation in the clinical management of prostate can- cer. Endocr Relat Cancer 2006; 13(2): 357-77.
10Bloom JS, Khan Z, Kruglyak L, Singh M, Caudy AA. Measuring differential gene expression by short read sequencing: Quantita- tive comparison to 2-channel gene expression microarrays. BMC Genomics 2009; 10: 221.
